162 related articles for article (PubMed ID: 9351373)
1. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.
Li SR; Yang Q; Koller E; Kurtaran A; Bischof C; Leimer M; Rauscha F; Pidlich J; Virgolini I
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2066-73. PubMed ID: 9351373
[TBL] [Abstract][Full Text] [Related]
2. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.
Virgolini I; Li S; Sillaber C; Majdic O; Sinzinger H; Lechner K; Bettelheim P; Valent P
J Biol Chem; 1992 Jun; 267(18):12700-8. PubMed ID: 1377673
[TBL] [Abstract][Full Text] [Related]
3. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.
Eggerman TL; Andersen NH; Robertson RP
J Pharmacol Exp Ther; 1986 Mar; 236(3):568-73. PubMed ID: 2869139
[TBL] [Abstract][Full Text] [Related]
4. Acetylsalicylic acid (ASA) protects the prostaglandin-cAMP-system of human hypernephroma cells against irradiation-induced alterations.
Li SR; Yang Q; Wandl E; Pirker W; Virgolini I
Br J Cancer; 1993 Oct; 68(4):695-701. PubMed ID: 7691143
[TBL] [Abstract][Full Text] [Related]
5. Characterization of LDL and VLDL binding sites on human basophils and mast cells.
Virgolini I; Li SR; Yang Q; Koller E; Sperr WR; Leimer M; Angelberger P; Nimpf J; Schneider W; Valent P
Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):17-26. PubMed ID: 7538422
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.
Sharif NA; Xu SX; Williams GW; Crider JY; Griffin BW; Davis TL
J Pharmacol Exp Ther; 1998 Aug; 286(2):1094-102. PubMed ID: 9694973
[TBL] [Abstract][Full Text] [Related]
7. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s.
Watanabe T; Yatomi Y; Sunaga S; Miki I; Ishii A; Nakao A; Higashihara M; Seyama Y; Ogura M; Saito H
Blood; 1991 Nov; 78(9):2328-36. PubMed ID: 1718495
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin moieties that determine receptor binding specificity in the bovine corpus luteum.
Anderson LE; Schultz MK; Wiltbank MC
J Reprod Fertil; 1999 May; 116(1):133-41. PubMed ID: 10505064
[TBL] [Abstract][Full Text] [Related]
9. [Prostaglandin interaction in the human liver].
Virgolini I; Weiss K; Hermann M; Müller C; Sinzinger H
Klin Wochenschr; 1989 Dec; 67(24):1229-35. PubMed ID: 2483738
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of prostaglandin-receptors in human and rat liver: interspecies differences at the prostaglandin receptor-level.
Virgolini I; Müller C; Hermann M; Schütz W; Sinzinger H
Prostaglandins; 1988 Dec; 36(6):807-18. PubMed ID: 2469102
[TBL] [Abstract][Full Text] [Related]
11. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
[TBL] [Abstract][Full Text] [Related]
12. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
Ashby B
Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 binding sites in human renal tissue: characterization and localization by radioligand binding and autoradiography.
Eriksson LO; Larsson B; Hedlund H; Andersson KE
Acta Physiol Scand; 1990 Jul; 139(3):393-404. PubMed ID: 2173350
[TBL] [Abstract][Full Text] [Related]
14. Effects of purinergic agents on human mononuclear phagocytes are differentiation dependent. Implications for atherogenesis.
Müller G; Kerkhoff C; Hankowitz J; Pataki M; Kovacs E; Lackner KJ; Schmitz G
Arterioscler Thromb; 1993 Sep; 13(9):1317-26. PubMed ID: 8395878
[TBL] [Abstract][Full Text] [Related]
15. Platelet prostacyclin binding in smokers.
Jaschonek K; Weisenberger H; Tidow S; Daiss W; Renn W; Ostendorf P
J Lab Clin Med; 1986 Aug; 108(2):88-95. PubMed ID: 3016128
[TBL] [Abstract][Full Text] [Related]
16. PGE2 binding sites and PG-stimulated cyclic AMP accumulation in rat isolated glomeruli and glomerular cultured cells.
Friedlander G; Chansel D; Sraer J; Bens M; Ardaillou R
Mol Cell Endocrinol; 1983 May; 30(2):201-14. PubMed ID: 6133804
[TBL] [Abstract][Full Text] [Related]
17. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
Miller OV; Gorman RR
J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
[TBL] [Abstract][Full Text] [Related]
18. Specific prostaglandin E2 binding sites in isolated rat glomeruli: evidence for glomerular PGE receptors.
Chaudhari A; Kirschenbaum MA
Prostaglandins Leukot Med; 1985 Oct; 20(1):55-68. PubMed ID: 2866541
[TBL] [Abstract][Full Text] [Related]
19. Modulation of 3H-prostaglandin E2 binding sites in the rabbit gastric mucosa.
Tomoi M; Matsuo M; Ono T; Shibayama F
Prostaglandins; 1990 Feb; 39(2):113-22. PubMed ID: 2107564
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandins as reducing agents: a model of adenylate cyclase activation?
Peterson DA; Kelly B; Mehta N; Gerrard JM
Prostaglandins; 1988 Nov; 36(5):667-71. PubMed ID: 2853423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
